A 60-year-old woman infected with HMPV infection during treatment in Lucknow. Hospital officials have cited other medical ...

Kerendia helps prevent or delay kidney failure in diabetic patients, while Verquvo is designed to reduce hospitalisation rates in patients with worsening heart ... in Bayer Zydus Pharma from ...

Lipid profile, heart health and fitness screening – these are some new ... chief clinical nutritionist at Zydus Hospitals in Ahmedabad, has encountered from her clients. “Now people are coming to me ...

Bayer's expanded therapies and strategic collaborations in India aim to drive pharmaceutical growth amidst regulatory challenges and pricing pressures.

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb trial of its oral NLRP3 inflammasome inhibitor, Usnoflast, for ...

Zydus, a leading, discovery-based, global pharmaceutical company announced that the US FDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of ...

Zydus Lifesciences announced that it has entered into an agreement with CVS Caremark, a CVS Health (CVS) company, to add Zituvio, Zituvimet and Zituvimet XR tablets to its template formulary.

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

Jan. 22, 2025 — A new national survey found that while many Americans use a device to monitor their heart, few share that data with their ... Study Shows Anti-Clotting Drug Reduced Bleeding ...

Our editors also may be in touch with follow-up questions. An elevated heart rate as a result of physical activity, such as going for a run, is common, but what should your heart rate look like at ...